Atagabalin

CAS No. 223445-75-8

Atagabalin( PD 0200390 )

Catalog No. M13581 CAS No. 223445-75-8

Atagabalin (PD 0200390) is a novel ligand of the voltage-dependent calcium channel (VDCC) α2δ subunit (1 and 2) for treatment for insomnia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Atagabalin
  • Note
    Research use only, not for human use.
  • Brief Description
    Atagabalin (PD 0200390) is a novel ligand of the voltage-dependent calcium channel (VDCC) α2δ subunit (1 and 2) for treatment for insomnia.
  • Description
    Atagabalin (PD 0200390) is a novel ligand of the voltage-dependent calcium channel (VDCC) α2δ subunit (1 and 2) for treatment for insomnia.Sleep Disorder Phase 2 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PD 0200390
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    Neurological Disease
  • Indication
    Sleep Disorder

Chemical Information

  • CAS Number
    223445-75-8
  • Formula Weight
    185.267
  • Molecular Formula
    C10H19NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)CC1(CN)C[C@H](C)[C@@H](C)C1
  • Chemical Name
    2-((3S,4S)-1-(aminomethyl)-3,4-dimethylcyclopentyl)acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Blakemore DC, et al. Bioorg Med Chem Lett. 2010 Jan 15;20(2):461-4. 2. Quintero JE, et al. Brain Res. 2011 Jul 15;1401:1-9.
molnova catalog
related products
  • CRAC intermediate 1

    CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors.

  • Gallopamil hydrochlo...

    Gallopamil hydrochloride is an antagonist of phenylalkylamine calcium. Gallopamil hydrochloride can be used in antiarrhythmic and vasodilator studies.

  • AMG1

    A novel specific CRAC channel inhibitor that blocks function of effector.